Methods matter: What steps are companies taking to help curb AMR by manufacturing responsibly?

The discharge of antibiotic waste that contains active pharmaceutical ingredients into the environment is a key driver of antimicrobial resistance (AMR). It explores the current state of play and highlights three actions that your company can take to manufacture responsibly, including employing effective methods to reduce AMR risks; promoting compliance with discharge limits across the supply chain; and transparently disclosing responsible manufacturing practices.